- OnLife® for the dietary treatment of chemotherapy-induced metabolic disorders of the peripheral nervous system
OnLife® for the dietary treatment of chemotherapy-induced metabolic disorders of the peripheral nervous system
OnLife®, previously sold as KapDolen, is a new patented combination of physiological (endogenous) fatty acids and palmitoyl-ethanol-amide (PEA). It is approved as a balanced diet. Balanced diets are defined as "dietetic foods for special medical purposes". In the case of CIPN, in which the function of the cell membranes is disturbed by the nerve-damaging effects of chemotherapy and radiation therapy, the dietary food OnLife® can be used to help restore the correct function of the membrane of the nerve cell. OnLife® is based on the “Fatty Acids Group”, or F. A. G.® for short, a new, standardized combination of polyunsaturated omega-3 fatty acids, other specific fatty acids, palmitoyl ethanol amide (PEA) and linolenic acids. Omega-3 fatty acids are believed to have a preventive effect in relation to cancer. A good supply of omega-3s can also reduce the side effects of chemotherapy (CIPN).
- 30 tablets
- Medical device, available for sale without a prescription
For the dietary treatment of chemotherapy-induced metabolic disorders of the peripheral nervous system.
- Application Area
- Hands, Feet
- Dosage Form
- Subject Area
- Oncology Care
- Men & Women
- 30 pcs.
- Refund Warranty